Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$642.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jun 12 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $26.52 | $265.2K | +17.8% | Open the original filing on SEC.gov |
| Jun 9 | VIR | Vir Biotechnology, Inc. | AGRANT◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | VIR | Vir Biotechnology, Inc. | AGRANT◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | VIR | Vir Biotechnology, Inc. | AGRANT | 8,000 | — | — | +100.0% | Open the original filing on SEC.gov |
| Jun 9 | VIR | Vir Biotechnology, Inc. | AGRANT | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | ADCT | ADC Therapeutics SA | FTAX | 12,600 | $3.08 | $38.8K | -14.8% | Open the original filing on SEC.gov |
| Jun 1 | ADCT | ADC Therapeutics SA | AGRANT | 45,000 | — | — | +112.5% | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT | 4,000 | — | — | +7.7% | Open the original filing on SEC.gov |
| May 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 3,250 | $43.49 | $141.3K | -5.9% | Open the original filing on SEC.gov |
| May 11 | ATYR | aTYR PHARMA INC | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |